Diane Kilbride, APRN
Nurse Practitioner · Jeffersonville, INNPI 1326307018
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,927 of the $10,823 with a category attached, or 73.2%. Medtronic accounts for 71.6% of it on its own, with 26 other manufacturers making up the rest. Among nurse practitioner clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 309 payments — averaging $35.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$8K
- Sumitomo Pharma America, Inc.$648
- Teleflex LLC$528
- Endo Pharmaceuticals Inc.$377
- AbbVie$335
- Procept Biorobotics Corporation$210
- plus $978 from 21 others
What the payments were for
- Speaking & faculty fees$1,50814%
- Travel & lodging$1,32112%
- Food & beverage$7,92773%
- Education$681%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 199 | $7,747 |
| Sumitomo Pharma America, Inc. | 27 | $648 |
| Teleflex LLC | 5 | $528 |
| Endo Pharmaceuticals Inc. | 17 | $377 |
| AbbVie | 18 | $335 |
| Procept Biorobotics Corporation | 2 | $210 |
| Ferring Pharmaceuticals Inc. | 3 | $189 |
| Urogen Pharma, Inc. | 4 | $167 |
| Axonics, Inc. | 4 | $112 |
| Antares Pharma, Inc. | 6 | $101 |
| E.r. Squibb & Sons, L.L.C. | 3 | $51 |
| Endo USA, Inc. | 2 | $49 |
| Merck | 2 | $37 |
| Myovant Sciences Inc. | 2 | $32 |
| Johnson & Johnson | 2 | $30 |
| Astellas Pharma US Inc | 2 | $29 |
| Tolmar, Inc. | 1 | $26 |
| Blue Earth Diagnostics | 1 | $21 |
| Boston Scientific | 1 | $20 |
| Verity Pharmaceuticals Inc. | 1 | $18 |
| Accord Healthcare, Inc. | 1 | $17 |
| Tolmar Pharmaceuticals, Inc. | 1 | $15 |
| Myriad Genetic Laboratories, Inc. | 1 | $15 |
| Coloplast | 1 | $14 |
| Pfizer | 1 | $14 |
| Progenics Pharmaceuticals, Inc. | 1 | $14 |
| Clarus Therapeutics Inc. | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTERSTIM$3,953
- UroLift System$377
- AquaBeam Robotic System$173
- ADSTILADRIN$150
- ALTAVIVA$141
- UroLift$130
How this compares
$10,823 in reported general payments places this provider in the 95th percentile of 2,724 nurse practitioner providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 519 | $353,527 |
| MyrbetriqMirabegron | 358 | $229,756 |
| Mirabegron ErMirabegron | 22 | $9,642 |
| Tamsulosin Hcl | 458 | $9,148 |
| Estradiol | 20 | $1,730 |
| Finasteride | 93 | $1,662 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 133 | $1,474 |
| Trospium Chloride ErTrospium Chloride | 18 | $1,455 |
| Cephalexin | 118 | $1,218 |
| Solifenacin Succinate | 51 | $877 |
| Oxybutynin Chloride | 31 | $779 |
| Fesoterodine Fumarate ErFesoterodine Fumarate | 12 | $492 |
| Doxazosin Mesylate | 30 | $477 |
| Oxybutynin Chloride ErOxybutynin Chloride | 16 | $427 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 49 | $382 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $648 | $353,527519 claims |
| Astellas Pharma US IncMyrbetriq | $29 | $229,756358 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,724 nurse practitioner providers in Indiana.
Other nurse practitioner in Jeffersonville
- Kelly GollarJeffersonville$11K
- Kristi OrbaughIndianapolis$1.3M
- Kimberly EadsPlainfield$302K
- Sean GoddardFort Wayne$180K
- Kacy RogersIndianapolis$77K
- Kristine TaylorFort Wayne$69K
- Brittany SavageIndianapolis$51K
- Monica HaugerTrafalgar$47K
- Rhonda HettingerClarksville$38K
- Jennifer MaahsIndianapolis$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.